BioTelemetry
BEAT
BEAT was delisted on the 8th of February, 2021.
195 hedge funds and large institutions have $840M invested in BioTelemetry in 2017 Q2 according to their latest regulatory filings, with 36 funds opening new positions, 69 increasing their positions, 68 reducing their positions, and 19 closing their positions.
89% more first-time investments, than exits
New positions opened: 36 | Existing positions closed: 19
80% more capital inflows, than outflows
Capital inflows: $166M | Capital outflows: $92.3M
35% more call options, than puts
Call options by funds: $10.4M | Put options by funds: $7.68M
10% more funds holding
Funds holding: 178 → 195 (+17)
6.4% more ownership
Funds ownership: 81.22% → 87.61% (+6.4%)
1% more repeat investments, than reductions
Existing positions increased: 69 | Existing positions reduced: 68
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Hood River Capital Management
Palm Beach Gardens,
Florida
|
+$23.8M |
| 2 |
Russell Investments Group
London,
United Kingdom
|
+$15.5M |
| 3 |
Bank of New York Mellon
New York
|
+$15.1M |
| 4 |
Hodges Capital Management
Dallas,
Texas
|
+$13.1M |
| 5 |
Castleark Management
Chicago,
Illinois
|
+$10.5M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Acadian Asset Management
Boston,
Massachusetts
|
-$7.58M |
| 2 |
Bogle Investment Management
Newton Lower Falls,
Massachusetts
|
-$6.91M |
| 3 |
Cannell Capital
Alta,
Wyoming
|
-$6.83M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$4.85M |
| 5 |
Renaissance Technologies
New York
|
-$4.82M |
BEAT Hedge Fund Activity: Q2 2017 in Review
195 of the 4,025 institutional investors tracked by Wall St. Rank reported a position in BioTelemetry (BEAT) for Q2 2017, worth a combined $840M — up 27% from $661M a quarter earlier.
Buyers outnumbered sellers: 36 funds opened new BEAT positions and 19 closed out — a net gain of 17 holders — while 69 added to existing stakes and 68 trimmed.
The largest buyer was Hood River Capital Management, opening a new position worth an estimated $23.8M. The largest seller was Acadian Asset Management, cutting an estimated $7.58M.
- 195 institutional investors held BioTelemetry (BEAT) as of Q2 2017, up from 178 in Q1 2017.
- Funds reported $840M of BioTelemetry stock for Q2 2017, up 27% quarter-over-quarter.
- 36 funds opened new BioTelemetry positions in Q2 2017 and 19 closed out, a net change of +17 holders.
- The largest BioTelemetry buyer in Q2 2017 was Hood River Capital Management, an estimated $23.8M added.
- The largest BioTelemetry seller in Q2 2017 was Acadian Asset Management, an estimated $7.58M sold.
Based on aggregated 13F filings for Q2 2017.